1. Home
  2. FA vs PGEN Comparison

FA vs PGEN Comparison

Compare FA & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Advantage Corporation

FA

First Advantage Corporation

N/A

Current Price

$18.30

Market Cap

3.4B

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$8.25

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FA
PGEN
Founded
2003
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
FA
PGEN
Price
$18.30
$8.25
Analyst Decision
Buy
Buy
Analyst Count
10
4
Target Price
★ $26.25
$13.65
AVG Volume (30 Days)
1.2M
★ 3.6M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 72.97
N/A
EPS
★ 0.11
0.03
Revenue
★ $1,574,389,000.00
$230,981,000.00
Revenue This Year
$8.35
$2,365.68
Revenue Next Year
$6.69
$85.75
P/E Ratio
★ $160.59
$271.00
Revenue Growth
★ 83.02
N/A
52 Week Low
$8.82
$2.99
52 Week High
$25.15
$8.27

Technical Indicators

Market Signals
Indicator
FA
PGEN
Relative Strength Index (RSI) 34.18 72.48
Support Level $14.34 $6.41
Resistance Level $21.43 N/A
Average True Range (ATR) 0.68 0.45
MACD -0.35 0.09
Stochastic Oscillator 12.01 84.01

Price Performance

Historical Comparison
FA
PGEN

About FA First Advantage Corporation

First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: